erythromycin has been researched along with thiazolyl blue in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hofsli, E; Nissen-Meyer, J | 1 |
| Tuominen, RK; Vainio, PJ; Viluksela, M | 1 |
| Bao, K; Li, P; Lin, J; Tian, L; Wu, L; Zhang, W | 1 |
3 other study(ies) available for erythromycin and thiazolyl blue
| Article | Year |
|---|---|
Effect of erythromycin and tumour necrosis factor on the drug resistance of multidrug-resistant cells: reversal of drug resistance by erythromycin.
Topics: Animals; Antineoplastic Agents; Coloring Agents; Dactinomycin; Doxorubicin; Drug Interactions; Drug Resistance; Drug Synergism; Erythromycin; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Verapamil | 1989 |
Cytotoxicity of macrolide antibiotics in a cultured human liver cell line.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Line; Clarithromycin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Epithelial Cells; Epithelium; Erythromycin; Humans; Liver; Proteins; Roxithromycin; Tetrazolium Salts; Thiazoles | 1996 |
Immunomodulatory effects of erythromycin and its derivatives on human T-lymphocyte in vitro.
Topics: Anti-Bacterial Agents; Blotting, Western; Cell Proliferation; Cells, Cultured; Erythromycin; Flow Cytometry; Humans; Immunologic Factors; In Situ Nick-End Labeling; Jurkat Cells; NF-kappa B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stimulation, Chemical; T-Lymphocytes; Tetrazolium Salts; Thiazoles | 2007 |